Moberg Pharma
36,5 SEK -2,82%5 investorer følger denne virksomhed
Moberg Pharma is a Swedish pharmaceutical company focused on the commercialization of proprietary medicines based on proven substances. The company mainly works in nail fungus, where Moberg Pharma is developing a new external treatment. The company has agreements with commercial partners on site in Europe and Asia, among other places. The head office is in Bromma.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
MOB
Daglig lav / høj pris
36,5 / 39
SEK
Markedsværdi
1,75 mia. SEK
Aktieomsætning
11,96 mio. SEK
Volumen
317 t
Seneste videoer
Finanskalender
Delårsrapport
13.08.2024
Delårsrapport
12.11.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Östersjöstiftelsen | 11,5 % | 11,5 % |
Avanza Pension | 6,4 % | 6,4 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Moberg Pharma receives SEK 336 million through TO 2 and directed issue to top guarantors - subscription rate in TO 2 of 98%
The last day for trading in Moberg Pharma's warrants of series 2023:1 (TO 2) is today, June 17[th], 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools